Physician profile
Eric P Xanthopoulos
NPI 1457693079
$3,486.85
in general payments reported to CMS, 2019-2025
53 companies · $548 in 2025
The $548 reported for 2025 was more than what 76% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $169 · 2021: $700 · 2022: $874 · 2023: $613 · 2024: $406 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $418.17 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Astrazeneca Pharmaceuticals LP | $305.52 | 2020-2024 | Imfinzi |
| Bayer Healthcare Pharmaceuticals INC. | $233.49 | 2021-2023 | |
| Incyte Corporation | $227.47 | 2019-2025 | Jakafi |
| Genzyme Corporation | $176.96 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $160.68 | 2023-2025 | |
| Amgen INC. | $156.92 | 2019-2023 | Kyprolis |
| Astellas Pharma US INC | $152.41 | 2020-2025 | Padcev, Xtandi, Cresemba |
| Abbvie INC. | $147.26 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $104.33 | 2019-2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.90 | 2022-2023 | Gilotrif |
| Regeneron Healthcare Solutions, INC. | $89.84 | 2021-2023 | Libtayo |
| Rigel Pharmaceuticals, INC. | $83.54 | 2021-2022 | |
| Gilead Sciences, INC. | $82.33 | 2021-2022 | |
| Blueprint Medicines Corporation | $82.19 | 2022-2025 | Ayvakit |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Xanthopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.